genprowebdirectory
GEN Edge
News
Insights
Trends for 2021
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Coronavirus
Synthetic Data for a Real Pandemic
Gene Therapy
Bayer Approach to Partnerships, Pipelines, and Platforms
Genomics
Genomics in the Clinic: A Candid Conversation with Sema4 CEO Eric…
Circulating Tumor Cell
Illumina Launching Pan-Cancer IVD Test, Cloud-Based Bioinformatics Platform
Biomarkers
Guardant Health Launches Early-Stage Colorectal Cancer ctDNA Assay
News
Coronavirus
Merck Halves COVID-19 Pipeline; Halts Two Vaccines, Continues Two Drugs
Neuroscience
Hi-Tech Electrical Probes Reveal Visual Information Flow Mirrors Structural Organization
Coronavirus
Biden’s COVID-19 Plan Emphasizes Vaccines, Masks, and Trust
News
Researchers Shine a Light on UV Light Exposure and Kidney Damage
Metagenomics
Metagenomics Analysis Finds 90% of U.S. Infants Studied Lack Key Gut…
Insights
All
Trends for 2021
Trends for 2020
Bioprocessing
Biopharma Manufacturers Shouldn’t Rush When “Going Digital”
Bioprocessing
Separating Cells with Microfluidics
Trends for 2021
Beyond 2021: Cell Therapy Manufacturing Trends
Bioprocessing
Machine Learning for Better Bioprocess Data Analysis
A-Lists
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Upcoming Webinars
Accelerating Vaccine Development and Large-Scale Manufacturing with Advanced Purification Tools
Coronavirus
Merck Halves COVID-19 Pipeline; Halts Two Vaccines, Continues Two Drugs
Coronavirus
Biden’s COVID-19 Plan Emphasizes Vaccines, Masks, and Trust
Metagenomics
Metagenomics Analysis Finds 90% of U.S. Infants Studied Lack Key Gut…
Magazine
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
January 2021 Vol. 41 No. 1
Leroy Hood: Reflections on a Legendary Career
January 2021 Vol. 41 No. 1
COVID-19 One Year Later: The Biology and the Business
Traditional Medicine
Monoclonal Antibodies: Developers Explore New Territories
Roundtable
Uncharted Territory: Top Challenges Facing Gene Therapy Development
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Antibodies
Monoclonal Antibodies
Page 2
Monoclonal Antibodies
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Monoclonal Antibodies
Dengue Virus Blocking Antibody Identified
Monoclonal Antibodies
Customized Glycoengineering in Plant-Based Expression Systems
Monoclonal Antibodies
FDA OKs Emergency Use of Regeneron’s COVID-19 Antibody “Cocktail”
Monoclonal Antibodies
WuXi and AC Immune Expand Strategic Partnership
Monoclonal Antibodies
FDA Authorizes Emergency Use of Lilly’s COVID-19 Antibody Bamlanivimab
Monoclonal Antibodies
Cancer Cells Exploit Double Bind in Immune Escape Act
Monoclonal Antibodies
RenMab™ Mouse Set to Become the Leading Platform for Generating Human...
Monoclonal Antibodies
Celgene Scraps $2.6B Deal, Licenses Jounce Antibody in Restructured Cancer Collaboration
Monoclonal Antibodies
BioNTech Boosting Pipeline, Manufacturing, Global Presence with $325M in Series B...
Monoclonal Antibodies
End Uncertainty: Break Through the Roadblocks to Monoclonal Antibody (mAb) Characterization
Monoclonal Antibodies
Genentech’s Crenezumab Fails Two Phase III Trials in Alzheimer’s
Monoclonal Antibodies
BioNTech to Acquire MAB Discovery’s Antibody Generation Unit, Building on Six-Year...
Monoclonal Antibodies
What Makes a Successful Therapeutic Monoclonal Antibody?
Monoclonal Antibodies
Peaceable Gut Microbiota Express Symbiosis-Promoting Factors in Response to IgA
Monoclonal Antibodies
Otsuka to Acquire Visterra for $430M, Adding to Its Pipeline and...
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
